Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content
Family Health History PHGKB

Specific PHGKB|Family Health History PHGKB|PHGKB

Last Posted: May 10, 2022
spot light Spotlight

Family history tools for primary care: A systematic review.
Miroševic Špela et al. The European journal of general practice 2022 28(1) 75-86

This review explores the FH tools currently available for PC and evaluates their clinical performance.Five databases were systematically searched until May 2021. Identified tools were evaluated on the following criteria: time-to-complete, integration with electronic health record (EMR) systems, patient administration, risk-assessment ability, evidence-based management recommendations, analytical and clinical validity and clinical utility.We identified 26?PC FH tools. Analytical and clinical validity was poorly reported and agreement between FH and gold standard was commonly inadequately reported and assessed. Sensitivity was acceptable; specificity was found in half of the reviewed tools to be poor. Most reviewed tools showed a capacity to successfully identify individuals with increased risk of disease (6.2-84.6% of high and/or moderate or increased risk individuals).Despite the potential of FH tools to improve risk stratification of patients in PC, clinical performance of current tools remains limited as well as their integration in EMR systems. Twenty-one FH tools are designed to be self-administered by patients.

Chronic Kidney Disease Basics
CDC, March 2022

Kidney diseases are a leading cause of death in the United States. About 37 million US adults are estimated to have CKD, and most are undiagnosed. 40% of people with severely reduced kidney function (not on dialysis) are not aware of having CKD. Talk to your doctor about getting tested if you have any of these risk factors: Diabetes, High blood pressure, Heart disease, Family history of CKD, Obesity.

Advances in Breast Cancer-Screening and Treatment Get Personal
NIH News in Health, February 2022

Researchers are studying the risk factors for different types of breast cancer. They’re also searching for more personalized treatments. Breast cancer is caused by a combination of factors. Your genes, lifestyle, and environment all contribute to your risk. Researchers are trying to better understand how each plays a role. People with a family history of breast cancer are at increased risk for the disease. Some are born with rare versions of certain genes that put them at high risk. These include the genes BRCA1 and BRCA2. But the vast majority of patients have no known family history and no known gene that causes cancer.

Accounting for age of onset and family history improves power in genome-wide association studies.
Pedersen Emil M et al. American journal of human genetics 2022 2

Genome-wide association studies (GWASs) have revolutionized human genetics, allowing researchers to identify thousands of disease-related genes and possible drug targets. However, case-control status does not account for the fact that not all controls may have lived through their period of risk for the disorder of interest. This can be quantified by examining the age-of-onset distribution and the age of the controls or the age of onset for cases. The age-of-onset distribution may also depend on information such as sex and birth year. In addition, family history is not routinely included in the assessment of control status. Using simulation, we show that, when family history and the age-of-onset distribution are available, the proposed approach yields statistically significant power gains over LT-FH and large power gains over genome-wide association study by proxy (GWAX).

news Latest News and Publications
Association of Lipoprotein (a) in Coronary Artery Disease in Young Individuals. External Web Site Icon
Patted Aishwarya et al. The Journal of the Association of Physicians of India 2022 70(4) 11-12
Common data elements to standardize genomics studies in cerebral palsy. External Web Site Icon
Wilson Yana A et al. Developmental medicine and child neurology 2022
Heterozygous and Homozygous Variants in SORL1 Gene in Alzheimer's Disease Patients: Clinical, Neuroimaging and Neuropathological Findings. External Web Site Icon
Alvarez-Mora Maria Isabel et al. International journal of molecular sciences 2022 23(8)
Polygenic risk score as a possible tool for identifying familial monogenic causes of complex diseases. External Web Site Icon
Lu Tianyuan et al. Genetics in medicine : official journal of the American College of Medical Genetics 2022
Preconception leisure-time physical activity and family history of stroke and myocardial infarction associate with preterm delivery: findings from a Norwegian cohort. External Web Site Icon
Engen Tone et al. BMC pregnancy and childbirth 2022 22(1) 341
Prenatal genetic counseling practices regarding recommendations for cancer genetic counseling: A retrospective chart review from two academic institutions. External Web Site Icon
Saba Lisa F et al. Journal of genetic counseling 2022
Prevalence of Americans reporting a family history of cancer indicative of increased cancer risk: Estimates from the 2015 National Health Interview Survey. External Web Site Icon
Kumerow Marie T et al. Preventive medicine 2022 107062
Increased Number Of Colorectal Interval Cancers In Lynch Syndrome After The SARS-CoV-2 Pandemic. A Survey-based Study. External Web Site Icon
Russo Michele, et al. Digestive diseases (Basel, Switzerland) 2022 0 0.
Cost-effectiveness of artificial intelligence for screening colonoscopy: a modelling study. External Web Site Icon
Areia Miguel et al. The Lancet. Digital health 2022
Thrombosis Risk History and D-dimer Levels in Asymptomatic Individuals with Prader-Willi Syndrome. External Web Site Icon
Matesevac Lisa et al. Journal of clinical medicine 2022 11(7)
Tumor BRCA Testing in Epithelial Ovarian Cancers: Past and Future-Five-Years' Single-Institution Experience of 762 Consecutive Patients. External Web Site Icon
Fumagalli Caterina et al. Cancers 2022 14(7)
Association of Family History of Cancer with Clinical and Pathological Outcomes for Prostate Cancer Patients on Active Surveillance. External Web Site Icon
Jibara Ghalib A et al. The Journal of urology 2022 101097JU0000000000002668
Diagnostic validity and clinical utility of genetic testing for hypertrophic cardiomyopathy: a systematic review and meta-analysis. External Web Site Icon
Christian Susan et al. Open heart 2022 9(1)
Identification of Germline Mutations in Upper Tract Urothelial Carcinoma With Suspected Lynch Syndrome. External Web Site Icon
Guan Bao et al. Frontiers in oncology 2022 12774202
Interventions to improve delivery of cancer genetics services in the United States: A scoping review. External Web Site Icon
Bednar Erica M et al. Genetics in medicine : official journal of the American College of Medical Genetics 2022
BRCA mutations: Implications of genetic testing in ovarian cancer. External Web Site Icon
Talwar Vineet et al. Indian journal of cancer 2022 59(Supplement) S56-S67
Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program. External Web Site Icon
Bychkovsky Brittany L et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2022
Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies. External Web Site Icon
Xu Jianfeng et al. Prostate cancer and prostatic diseases 2022
Can Automated Alerts in the Electronic Health Record Encourage Referrals for Genetic Counseling and Testing Among Patients at High Risk for Hereditary Cancer Syndromes? External Web Site Icon
Zorn Kristin K et al. JCO oncology practice 2022 OP2100641
Do current family history-based genetic testing guidelines contribute to breast cancer health inequities? External Web Site Icon
Jakuboski Samantha H et al. NPJ breast cancer 2022 8(1) 36
Hereditary evaluation and genetic counselling in young individuals with colorectal cancer in a population-based cohort. External Web Site Icon
Lundqvist Erik et al. Surgical oncology 2022 41101741
Laboratory-related outcomes from integrating an accessible delivery model for hereditary cancer risk assessment and genetic testing in populations with barriers to access. External Web Site Icon
Amendola Laura M et al. Genetics in medicine : official journal of the American College of Medical Genetics 2022
Population-based screening of Uruguayan Ashkenazi Jews for recurrent BRCA1 and BRCA2 pathogenic sequence variants. External Web Site Icon
Castillo Cecilia et al. Molecular genetics & genomic medicine 2022 e1928
Prostate cancer incidence and survival in relation to prostate cancer as second cancer in relatives. External Web Site Icon
Zheng Guoqiao et al. Cancer medicine 2022
Time to Diagnosis of Duchenne Muscular Dystrophy Remains Unchanged: Findings from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet), 2000-2015. External Web Site Icon
Thomas Shiny et al. Muscle & nerve 2022
Universal Screening for Lynch Syndrome Compared with Pedigree-Based Screening: 10-Year Experience in a Tertiary Hospital. External Web Site Icon
Kim Min Hyun et al. Cancer research and treatment 2022
Nonlaboratory-based risk assessment model for coronary heart disease screening: Model development and validation. External Web Site Icon
Zhang Liying et al. International journal of medical informatics 2022 162104746
Familial Risk of Renal Cell Cancer and Interaction with Obesity and Hyperglycemia-A Population-Based Study. External Web Site Icon
Lee Sung Won et al. The Journal of urology 2022 101097JU0000000000002506
Investigating men's motivations to engage in genetic screening for BRCA1 and BRCA2 mutations. External Web Site Icon
Annoni Anna Maria et al. PloS one 2022 17(3) e0265387
Referral indications for malignant hyperthermia susceptibility diagnostics in patients without adverse anesthetic events in the era of next-generation sequencing. External Web Site Icon
van den Bersselaar Luuk R et al. Anesthesiology 2022


Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.